Jan. 19 at 2:03 PM
$BRCHF For those unaware, to get on a larger exchange, BrainChip would likely if they execute on their business with substantially higher top and bottom-line numbers via increased penetration, have to use the ADR BCHPY to do so. This is because major U.S. exchanges like the Nasdaq require a minimum bid price (typically
$4.00) that the 1:1 ordinary shares (BRCHF) currently lack, whereas the 1:40 ratio of the ADR already positions the ticker at a higher price point more suitable for an up listing. Furthermore, BrainChip management formally announced which I just became awaye of in early 2025 https://announcements.asx.com.au/asxpdf/20250227/pdf/06g1tj4fyg55c7.pdf that they are evaluating redomiciling to the U.S. to facilitate a major exchange listing, a strategic move intended to capture a more technologically savvy investor base and potentially re-rate the company's valuation as a domestic AI player. The company did note later in 2025 that they were still assessing market conditions and regulatory hurdles.